Search research articles
Contact Us
Filters
Showing results (1-10 of 163) with videos related to
Page
of 17
Sort By:
Clinical Advances in Hematology & Oncology : H&O
|
November 6, 2007
Translation of pharmacogenetic knowledge into cancer therapeutics
Wei Peng Yong, Federico Innocenti
Annals of the Academy of Medicine, Singapore
|
November 9, 2011
Germline genetic testing to predict drug response and toxicity in oncology--reality or fiction?
Thomas I P Soh, Wei Peng Yong
Current Drug Targets
|
March 31, 2012
Systemic therapies for pancreatic cancer--the role of pharmacogenetics
Ross A Soo, Wei-Peng Yong, Federico Innocenti
British Journal of Clinical Pharmacology
|
July 18, 2006
The role of pharmacogenetics in cancer therapeutics
Wei Peng Yong, Federico Innocenti, Mark J Ratain
Critical Reviews in Oncology/Hematology
|
March 8, 2016
Translating gastric cancer genomics into targeted therapies
Yvonne L E Ang, Wei Peng Yong, Patrick Tan
Plos One
|
September 10, 2016
Identification of Gastric Cancer Biomarkers Using 1H Nuclear Magnetic Resonance Spectrometry
Gokula Krishnan Ramachandran, Wei Peng Yong, Chen Hua Yeow
Clinical Chemistry and Laboratory Medicine
|
September 29, 2011
Recent progress and clinical importance on pharmacogenetics in cancer therapy
Thomas I Peng Soh, Wei Peng Yong, Federico Innocenti
Drug Metabolism Reviews
|
June 12, 2009
Clinical pharmacology and pharmacogenetics of gemcitabine
Andrea Wong, Ross A Soo, Wei-Peng Yong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2005
Effects of ketoconazole on glucuronidation by UDP-glucuronosyltransferase enzymes
Wei Peng Yong, Jacqueline Ramirez, Federico Innocenti, et al.
Pharmacogenomics
|
September 28, 2016
Capecitabine pharmacogenetics: historical milestones and progress toward clinical implementation
Nicholas Syn, Soo-Chin Lee, Boon-Cher Goh, et al.
Page
of 17
Search research articles
Search
Showing results (1-10 of 163) with videos related to
Sort By:
Page
of 17
Clinical Advances in Hematology & Oncology : H&O
|
November 6, 2007
Translation of pharmacogenetic knowledge into cancer therapeutics
Wei Peng Yong, Federico Innocenti
Annals of the Academy of Medicine, Singapore
|
November 9, 2011
Germline genetic testing to predict drug response and toxicity in oncology--reality or fiction?
Thomas I P Soh, Wei Peng Yong
Current Drug Targets
|
March 31, 2012
Systemic therapies for pancreatic cancer--the role of pharmacogenetics
Ross A Soo, Wei-Peng Yong, Federico Innocenti
British Journal of Clinical Pharmacology
|
July 18, 2006
The role of pharmacogenetics in cancer therapeutics
Wei Peng Yong, Federico Innocenti, Mark J Ratain
Critical Reviews in Oncology/Hematology
|
March 8, 2016
Translating gastric cancer genomics into targeted therapies
Yvonne L E Ang, Wei Peng Yong, Patrick Tan
Plos One
|
September 10, 2016
Identification of Gastric Cancer Biomarkers Using 1H Nuclear Magnetic Resonance Spectrometry
Gokula Krishnan Ramachandran, Wei Peng Yong, Chen Hua Yeow
Clinical Chemistry and Laboratory Medicine
|
September 29, 2011
Recent progress and clinical importance on pharmacogenetics in cancer therapy
Thomas I Peng Soh, Wei Peng Yong, Federico Innocenti
Drug Metabolism Reviews
|
June 12, 2009
Clinical pharmacology and pharmacogenetics of gemcitabine
Andrea Wong, Ross A Soo, Wei-Peng Yong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2005
Effects of ketoconazole on glucuronidation by UDP-glucuronosyltransferase enzymes
Wei Peng Yong, Jacqueline Ramirez, Federico Innocenti, et al.
Pharmacogenomics
|
September 28, 2016
Capecitabine pharmacogenetics: historical milestones and progress toward clinical implementation
Nicholas Syn, Soo-Chin Lee, Boon-Cher Goh, et al.
Page
of 17